Company: Structure Therapeutics Inc.
Symbol: GPCR (Nasdaq)
Description: They are a clinical stage global biopharmaceutical company aiming to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriters: Jefferies, SVB Securities, Guggenheim Securities, BMO Capital Markets
Link to Prospectus: Filed: 1-12-23
IPO Pipeline: Biotech Structure Therapeutics files registration statement